HTA Council Recommendation (as of 28 April 2026) As a final recommendation, the HTA Council positively recommends biannual ultrasound (US) combined with alpha fetoprotein (AFP) test as a screening test for adults at high risk to develop hepatocellular carcinoma (HCC) every 6 months, for financing by DOH and/or PhilHealth. Relevant Information Evidence and Relevant Documents continue reading : Biannual Ultrasound with Alfa-fetoprotein (AFP) for screening of patients at risk to develop hepatocellular carcinoma who have or have not progressed to cirrhosis